ARCHIVES

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013

Avon Awards $16.2 Million To Cancer Centers, Others.

April 6, 2001

BRM Phase 1-2 Task Orders Awarded

November 21, 1980

New Staff Proposals For Comprehensive Center Recognition Considered By NCAB

January 19, 1979

It’s “High Noon” For Cancer, Vice President Says

October 2, 1998

Robert Hall appointed government relations director for National Coalition for Cancer Survivorship.

April 30, 2004